United State Patent And Trademark Office

Provisional Patent Application Form provisional applications tempt stakeholders with the … The patent at issue was Purdue Pharma’s U.S. Patent 9,034,376, directed to controlled release oral dosage forms of oxycodone. The court … "rhCollagen"), announced that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for photocurable dermal fillers comprised of rhCollagen and
Patent Act Of 1790 of their invention in the Patent Act of 1790. And though it was repealed nearly 100 years later, coming as it did during the country’s Industrial Revolution resulted in more than 200,000 little … provisional patent application form provisional applications tempt stakeholders with the … The patent at issue was Purdue Pharma’s U.S. Patent 9,034,376,

April 17, 2019 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body’s …

Home page of the United States Patent and Trademark Office’s main web site. home page of the United States Patent and Trademark Office’s main web site. … Op-ed by USPTO Director Iancu and Deputy Director Peter honors legacy of famous nurse and patent office clerk.

State, Local, and Tribal Governments U.S. Patent and Trademark Office The U.S. Patent and Trademark Office is the agency responsible for granting U.S. patents and registering trademarks.

ISSUED PATENTS (PATENT GRANTS) Patent Official Gazettes (JUL 2, 2002 – PRESENT) … United States Patent and Trademark Office – An Agency of the Department of Commerce. United States Patent and Trademark Office – An Agency of the Department of Commerce. Browse By Topic .

USPTO - United States Patent and Trademark Office -  US Patent Office #rolfclaessen Memphis, TN, April 18, 2019 (GLOBE NEWSWIRE) — Memphis, TN – April 18, 2019 – Surge Holdings, Inc. ("Surge") (OTCQB:SURG), developer of the SurgePays™ retail blockchain network, is pleased to …

titled "Tannin-chitosan composites," by the United States Patent and Trademark Office. This patent expands Revive’s coverage for the delivery of cannabinoids in various delivery routes.